Skip to main content
OpenTrials
Completed

NCT Number: NCT06299722

Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents

We aim to include 60 children and adolescents aged 10 to 19 years who have undergone successful treatment for leukemia or lymphoma. Based on randomization, they will either 1) commence 16 weeks of training with STEEL or 2) commence 16 weeks of circuit training. STEEL training involves exercises for major muscle groups using free weights, body weight, or tailored machines. Circuit training is structured similarly to previous training for the target group and includes exercises using body weight, exercise balls, and rings. The training takes place in local centers either with friends or with other participants in the project. Before starting participation in the project, the child/adolescent and their parents or guardians will receive information about late effects, diet, sleep, and exercise, providing guidance and support regarding the project elements. The effects of the two training modalities will be evaluated based on self-reported quality of life, muscle strength, muscle mass, bone mineral content, fitness, and markers of metabolic syndrome (BMI, waist circumference, blood pressure, and blood analysis).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

10 year–19 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Århus University Hospital, Aarhus, Denmark

Loading trial locations.

About this study

The trial is designed as a national randomised clinical trial. Participants will be stratified by sex and block randomised (block sizes of 2 to 6) at 1:1 to either STEEL or the circuit training programme. A researcher not involved in the trial will generate the allocation sequence using a random number generator and is the only person who will know the block sizes. The study will be conducted at Aalborg University Hospital, Rigshospitalet, Odense University Hospital, and Aarhus University Hospital and was designed in collaboration with parents of childhood cancer survivors and an adult childhood cancer survivor suffering from late effects. Participants must attend three examinations at their respective hospitals: baseline and after 8 and 16 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ten to 19 years of age at the point of inclusion
  • A minimum of 12 months since the last chemotherapy with no upper limit
  • Ability to understand the physical intervention and general participant advice

Exclusion criteria

  • Participation in another research study that includes similar treatment
  • Pregnancy
  • Cardiac arrhythmia during exercise
  • Psychological disorders interfering with treatment
  • Presence of a clinical condition that needs immediate treatment
  • Planned surgeries within the subsequent 12 months that may interfere with performing exercises
  • Any contraindications to performing physical exercise as evaluated by the recruiting medical doctor

Treatment and study plan

STEEL

Other

Relatively heavy strength training

Circuit Training

Other

Circuit training

Primary outcomes

  1. Isometric strength

    Time frame: Baseline and at the 8-week and 16-week follow-ups

    Measured in Nm based on tests of knee extension and flexion and elbow extension and flexion using handheld dynamometry

Secondary outcomes

  1. Health-related quality of life

    Time frame: During baseline and at the 16-week follow-up

    We will use the Danish version of the Pediatric Quality of Life Inventory (PedsQL™) 4.0 Generic Core scales and the PedsQL™ Multidimensional Fatigue scales (5,9) to assess health-related quality of life. The PedsQL is a brief 23-item measurement model that evaluates quality of life in four areas: physical, emotional, social and school functioning. The questionnaire scores range from 0 to 100, and higher scores indicate better quality of life. The PedsQL™ Multidimensional Fatigue includes 18 questions related to fatigue and uses the same scoring as the PedsQL

  2. Step counts

    Time frame: Weekly throughout the 16-week intervention

    We will assess participants' step counts throughout the intervention using a Garmin vívosmart® 5 watch (Garmin Ltd., Kansas, USA).

  3. Caloric expenditure

    Time frame: Weekly throughout the 16-week intervention

    We will assess participants' caloric expenditure (KCAL) throughout the intervention using a Garmin vívosmart® 5 watch (Garmin Ltd., Kansas, USA).

  4. Maximal dynamic strength

    Time frame: During the first and last training sessions of the 16-week intervention

    we will test the 1 repetition maximum (RM) in the leg press and chest press machines

  5. Bone mineral density of the lumbar spine and body composition

    Time frame: During baseline and at the 16-week follow-up

    We will measure the bone mineral density of the lumbar spine (L1-L4) calculated as the Z-score and body composition (%body fat, lean body mass, and skeletal muscle mass) by a dual-energy-X-ray absorptiometry scanner located at each hospital.

  6. Grip strength and rate of force development

    Time frame: Baseline and at the 8-week and 16-week follow-ups

    Using a digital hand dynamometer, we will measure continuous isometric handgrip force and rate of force development.

  7. Muscular strength, endurance, and rate of force development

    Time frame: Baseline and at the 8-week and 16-week follow-ups

    We will use a 30-second sit-to-stand test to evaluate strength, endurance, and rate of force development of the lower extremities.

  8. Cardiorespiratory fitness and endurance

    Time frame: Baseline and at the 8-week and 16-week follow-ups

    We will perform a 6-minute walk test to evaluate cardiorespiratory fitness and walking endurance

  9. Exercise compliance and fidelity

    Time frame: Throughout the 16-week intervention

    Exercise compliance and fidelity will be measured using training diaries, which the participants fill out themselves after the unsupervised training sessions and by the physiotherapist during the supervised training sessions. Exercise compliance relates to whether the training sessions have been performed, and fidelity relates to whether the exercises have been performed as prescribed regarding the number of repetitions, sets, and intensity.

  10. Adverse events

    Time frame: Throughout the 16-week intervention

    Adverse events will be collected throughout the trial and graded 1 to 5 according to the Common Terminology Criteria for Adverse Events v4.03. Participants are asked to contact the responsible clinician at the hospital where they were enrolled as soon as they experience any adverse event.

  11. Movement-evoked pain

    Time frame: During baseline and at the 16-week follow-up

    We will use a 0 (no pain) to 10 (worst pain imaginable) Numerical Rating Scale to assess movement-evoked pain during the past week

  12. Satisfaction with the intervention

    Time frame: During the 16-week follow-up

    We will assess participant satisfaction with their respective intervention using a 5-point rank scale ranging from 'very dissatisfied' to 'very satisfied'.

  13. Blood glucose

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in mmol/L

  14. Glycated hemoglobin (Hba1c)

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in mmol/mol

  15. Insulin

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in mU/L

  16. Proinsulin c-peptide

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in ng/mL

  17. Total cholesterol

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in mmol/L

  18. High-density lipoprotein cholesterol

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in mmol/L

  19. Low-density lipoprotein cholesterol

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in mmol/L

  20. Very low-density lipoprotein cholesterol

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in mmol/L

  21. Triglycerides

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in mmol/L

  22. Glucagon

    Time frame: During baseline and at the 16-week follow-up

    Analysed from a blood sample and measured in pg/mL

  23. Homeostatic Model assessment for Insulin resistance score

    Time frame: During baseline and at the 16-week follow-up

    Calculated as fasting plasma glucose (mmol/L x fasting plasma glucose ((μU/L)/22.5) to estimate β-cell function (HOMA-B) and insulin-resistance (HOMA-IR2)

  24. Body Mass Index (BMI)

    Time frame: During baseline and at the 16-week follow-up

    Measured as kg/m² for adolescents aged 18 or 19 years and BMI standard deviation (SD) scores for children aged 10-17 years based on national reference material.

  25. Lean body mass

    Time frame: During baseline and at the 16-week follow-up

    Measured in kilograms based on dual-energy X-ray absorptiometry (DXA)

  26. Fat mass

    Time frame: During baseline and at the 16-week follow-up

    Measured in kilograms based on dual-energy X-ray absorptiometry (DXA)

  27. Android/gynoid fat distribution

    Time frame: During baseline and at the 16-week follow-up

    Measured in kilograms based on dual-energy X-ray absorptiometry (DXA) adjusted for sex and pubertal stage

  28. Abdominal circumference

    Time frame: During baseline and at the 16-week follow-up

    Measured in centimetres

  29. Self-reported Tanner staging

    Time frame: During baseline and at the 16-week follow-up

    Visual illustration of Tanner staging (I-V) regarding both genders

  30. Blood pressure

    Time frame: During baseline and at the 16-week follow-up

    Measured in mmHg

Sponsors and collaborators

Lead sponsor

Aalborg University

Other

Registry information

Official study title

Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents - The STEEL Study - a National Multicenter Randomised Controlled Study

Acronym: STEEL

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 8, 2024
Registry last updated
Jan 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.